Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.22), $0.17 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.